47,000 Shares in OrthoPediatrics Corp. $KIDS Bought by Paradigm Capital Management Inc. NY

Key Points

• Paradigm Capital Management acquired 47,000 OrthoPediatrics shares in the second quarter, worth approximately $899,000 and representing a 0.18% stake. Institutional investors collectively own 69.05% of the company.
• OrthoPediatrics exceeded quarterly expectations, reporting revenue of $70.51 million versus the $68.21 million consensus estimate and an adjusted loss of $0.26 per share compared with the expected $0.30 loss.
• Analyst sentiment remains favorable, with nine Buy ratings, one Hold and one Sell; the stock has a consensus “Moderate Buy” rating and a $26.44 price target, while recent targets rose as high as $35.

Paradigm Capital Management Inc. NY acquired a new position in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 47,000 shares of the company's stock, valued at approximately $899,000. Paradigm Capital Management Inc. NY owned 0.18% of OrthoPediatrics at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock worth $246,000 after buying an additional 645 shares during the last quarter. Millennium Management LLC grew its position in shares of OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company's stock valued at $16,172,000 after buying an additional 233,873 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in OrthoPediatrics by 112.3% during the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company's stock worth $4,937,000 after acquiring an additional 106,041 shares during the period. Jane Street Group LLC bought a new position in OrthoPediatrics in the first quarter worth about $389,000. Finally, American Century Companies Inc. lifted its holdings in OrthoPediatrics by 12.5% in the second quarter. American Century Companies Inc. now owns 34,486 shares of the company's stock worth $741,000 after acquiring an additional 3,828 shares during the last quarter. Institutional investors own 69.05% of the company's stock.

OrthoPediatrics Stock Down 2.3%

KIDS stock opened at $25.07 on Tuesday. The firm's 50-day moving average is $20.99 and its two-hundred day moving average is $18.47. The company has a market capitalization of $654.58 million, a price-to-earnings ratio of -14.92 and a beta of 0.98. OrthoPediatrics Corp. has a 52 week low of $14.42 and a 52 week high of $26.74. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The business had revenue of $70.51 million during the quarter, compared to analysts' expectations of $68.21 million. On average, analysts forecast that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. BTIG Research upped their target price on OrthoPediatrics from $24.00 to $29.00 and gave the company a "buy" rating in a report on Thursday, August 20th. Piper Sandler reiterated an "overweight" rating and set a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. TD Cowen reissued a "buy" rating on shares of OrthoPediatrics in a report on Monday, June 15th. Needham & Company LLC boosted their price objective on OrthoPediatrics from $30.00 to $35.00 and gave the company a "buy" rating in a research report on Wednesday, August 5th. Finally, Weiss Ratings upgraded OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source